Early research (Phase 1)Ended earlyNCT05067972What this trial is testingPF-07260437 in Advanced or Metastatic Solid TumorsWho this might be right forOvarian NeoplasmsEndometrial NeoplasmsBreast Neoplasms Pfizer 30
Testing effectiveness (Phase 2)Study completedNCT01567891What this trial is testingCT Antigen TCR-redirected T Cells for Ovarian Cancer.Who this might be right forOvarian Cancer Adaptimmune 9
Early research (Phase 1)Looking for participantsNCT06215950What this trial is testingA Clinical Research About CD70-targeted CAR-T in the Treatment of CD70-positive Advanced/Metastatic Gynecologic CancerWho this might be right forOvarian CancerCervix CancerMetastatic Cancer+2 more Chongqing Precision Biotech Co., Ltd 36
Large-scale testing (Phase 3)Study completedNCT00002568What this trial is testingCombination Chemotherapy With or Without Surgery in Treating Patients With Stage III Ovarian Epithelial CancerWho this might be right forOvarian Cancer Gynecologic Oncology Group 470
Testing effectiveness (Phase 2)Study completedNCT00004060What this trial is testingChemotherapy in Treating Patients With Recurrent, Metastatic, or Unresectable Ovarian, Fallopian Tube, or Peritoneal CancerWho this might be right forFallopian Tube CancerOvarian CancerPrimary Peritoneal Cavity Cancer Daiichi Sankyo
Not applicableStudy completedNCT04817501What this trial is testingPhenotypic Spectrum of CTCs in Tumors of the Female Reproductive SystemWho this might be right forBreast CancerOvarian CancerEndometrial Cancer Tomsk National Research Medical Center of the Russian Academy of Sciences 150
Not applicableUnknownNCT01258881What this trial is testingRetrospective Study of Ovarian Cancer Patients With Brain MetastasisWho this might be right forOvarian CancerBrain Metastases National Taiwan University Hospital 70
Large-scale testing (Phase 3)Study completedNCT00782145What this trial is testingA Web-Based Stem Cell Transplant Support System or Standard Care in Young Patients Undergoing Stem Cell Transplant and Their FamiliesWho this might be right forChronic Myeloproliferative DisordersLeukemiaLymphoma+6 more Tufts Medical Center 198
Testing effectiveness (Phase 2)Active Not RecruitingNCT06334432What this trial is testingSafety and Efficacy Study of NUV-1511 in Adult Patients With Advanced Solid TumorsWho this might be right forAdvanced Solid TumorHER2-negative Breast CancerMetastatic Castration-resistant Prostate Cancer (mCRPC)+2 more Nuvation Bio Inc. 466
Testing effectiveness (Phase 2)Looking for participantsNCT00722228What this trial is testingAutologous and Allogeneic Whole Cell Cancer Vaccine for Metastatic TumorsWho this might be right forColorectal CancerOvarian CancerGastric Cancer+4 more Hadassah Medical Organization 50
Testing effectiveness (Phase 2)Looking for participantsNCT05704621What this trial is testingSecondary Cytoreductive Surgery (CRS) in Patients With Relapsed Ovarian Cancer Who Have Progressed on PARP Inhibitor MaintenanceWho this might be right forOvarian CancerDrug Related Neoplasm/Cancer Korea University Guro Hospital 124
Testing effectiveness (Phase 2)Active Not RecruitingNCT04152499What this trial is testingPhase I-II, FIH, TROP2 ADC, Advanced Unresectable/Metastatic Solid Tumors, Refractory to Standard Therapies (KL264-01)Who this might be right forEpithelial Ovarian CancerGastric AdenocarcinomaGastroesophageal Junction Adenocarcinoma+7 more Klus Pharma Inc. 1,410
Early research (Phase 1)UnknownNCT00769613What this trial is testingEmergency Use of Donor Lymphocytes in Treating Patients Who Have Undergone Donor Stem Cell Transplant and Have Cytomegalovirus InfectionsWho this might be right forCancer Milton S. Hershey Medical Center 20
Early research (Phase 1)WithdrawnNCT04498520What this trial is testingAbexinostat, Palbociclib, and Fulvestrant for the Treatment of Breast or Gynecologic CancerWho this might be right forAnatomic Stage III Breast Cancer AJCC v8Anatomic Stage IIIA Breast Cancer AJCC v8Anatomic Stage IIIB Breast Cancer AJCC v8+32 more Pamela Munster
Early research (Phase 1)Looking for participantsNCT07755436What this trial is testingPhase 1 Study to Assess Safety, Tolerability, Pharmacokinetics, Immunogenicity, and Antitumor Activity of ARR-002 in Advanced or Metastatic Ovarian or Endometrial Cancer.Who this might be right forOvarian CancerEndometrial CancerPlatinum-resistant Ovarian Cancer (PROC)+2 more ArriVent BioPharma, Inc. 180
Testing effectiveness (Phase 2)Looking for participantsNCT06839144What this trial is testingInhibiting Beta-adrenergic and COX-2 Signaling During the Perioperative Period to Reduce Ovarian Cancer ProgressionWho this might be right forOvarian CancerOvarian Cancer Metastatic Recurrent Tel-Aviv Sourasky Medical Center 60
Testing effectiveness (Phase 2)UnknownNCT04398446What this trial is testingEffect of Hemp-CBD on Patients With CIPNWho this might be right forChemotherapy-induced Peripheral NeuropathyColorectal Cancer Stage IIColorectal Cancer Stage III+4 more Main Line Health 56
Early research (Phase 1)Active Not RecruitingNCT06238479What this trial is testingLY4101174 in Participants With Recurrent, Advanced or Metastatic Solid TumorsWho this might be right forMetastatic Solid TumorRecurrent Solid TumorAdvanced Solid Tumor+11 more Eli Lilly and Company 490
Early research (Phase 1)Active Not RecruitingNCT05277051What this trial is testingFirst-Time-in-Human Study of GSK4381562 in Participants With Advanced Solid TumorsWho this might be right forNeoplasms GlaxoSmithKline 152
Early research (Phase 1)Study completedNCT00004241What this trial is testing17-N-Allylamino-17-Demethoxygeldanamycin in Treating Patients With Advanced Epithelial Cancer, Malignant Lymphoma, or SarcomaWho this might be right forAIDS-related Peripheral/Systemic LymphomaAIDS-related Primary CNS LymphomaAnaplastic Large Cell Lymphoma+50 more National Cancer Institute (NCI) 60